Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 96
Filter
1.
Chest ; 143(6): 1699-1708, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23732584

ABSTRACT

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with pulmonary vasculopathy. OBJECTIVE: The purpose of this study was to determine whether sildenafil improves 6-min walk distance (6MWD) in subjects with IPF and right ventricular dysfunction. METHODS: The IPFnet, a network of IPF research centers in the United States, conducted a randomized trial examining the effect of sildenafil on 6MWD in patients with advanced IPF, defined by carbon monoxide diffusing capacity < 35% predicted. A substudy examined 119 of 180 randomized subjects where echocardiograms were available for independent review by two cardiologists. Right ventricular (RV) hypertrophy (RVH), right ventricular systolic dysfunction (RVSD), and right ventricular systolic pressure (RVSP) were assessed. Multivariable linear regression models estimated the relationship between RV abnormality, sildenafil treatment, and changes in 6MWD, St. George's Respiratory Questionnaire (SGRQ), the EuroQol instrument, and SF-36 Health Survey (SF-36) from enrollment to 12 weeks. RESULTS: The prevalence of RVH and RVSD were 12.8% and 18.6%, respectively. RVSP was measurable in 71 of 119 (60%) subjects; mean RVSP was 42.5 mm Hg. In the subgroup of subjects with RVSD, subjects treated with sildenafil experienced less decrement in 6MWD (99.3 m; P = .01) and greater improvement in SGRQ (13.4 points; P = .005) and EuroQol visual analog scores (17.9 points; P = .04) than subjects receiving placebo. In the subgroup with RVH, sildenafil was not associated with change in 6MWD (P = .13), but was associated with greater relative improvement in SGRQ (14.8 points; P = .02) vs subjects receiving placebo. Sildenafil treatment in those with RVSD and RVH was not associated with change in SF-36. CONCLUSIONS: Sildenafil treatment in IPF with RVSD results in better preservation of exercise capacity as compared with placebo. Sildenafil also improves quality of life in subjects with RVH and RVSD.


Subject(s)
Hypertrophy, Right Ventricular/drug therapy , Hypertrophy, Right Ventricular/physiopathology , Idiopathic Pulmonary Fibrosis/drug therapy , Idiopathic Pulmonary Fibrosis/physiopathology , Piperazines/therapeutic use , Quality of Life , Sulfones/therapeutic use , Vasodilator Agents/therapeutic use , Ventricular Dysfunction, Right/drug therapy , Ventricular Dysfunction, Right/physiopathology , Walking/physiology , Aged , Chi-Square Distribution , Double-Blind Method , Echocardiography , Female , Humans , Hypertrophy, Right Ventricular/diagnostic imaging , Idiopathic Pulmonary Fibrosis/diagnostic imaging , Male , Placebos , Purines/therapeutic use , Regression Analysis , Respiratory Function Tests , Sildenafil Citrate , Statistics, Nonparametric , Surveys and Questionnaires , Ventricular Dysfunction, Right/diagnostic imaging
2.
J Immunol ; 188(8): 3940-8, 2012 Apr 15.
Article in English | MEDLINE | ID: mdl-22422883

ABSTRACT

We investigated mechanisms by which TLR9 signaling promoted the development of the protective response to Cryptococcus neoformans in mice with cryptococcal pneumonia. The afferent (week 1) and efferent (week 3) phase immune parameters were analyzed in the infected wild-type (TLR9(+/+)) and TLR-deficient (TLR9(-/-)) mice. TLR9 deletion diminished 1) accumulation and activation of CD11b(+) dendritic cells (DCs), 2) the induction of IFN-γ and CCR2 chemokines CCL7, CCL12, but not CCL2, at week 1, and 3) pulmonary accumulation and activation of the major effector cells CD4(+) and CD8(+) T cells, CD11b(+) lung DCs, and exudate macrophages at week 3. The significance of CCL7 induction downstream of TLR9 signaling was investigated by determining whether CCL7 reconstitution would improve immunological parameters in C. neoformans-infected TLR9(-/-) mice. Early reconstitution with CCL7 1) improved accumulation and activation of CD11b(+) DCs at week 1, 2) restored early IFN-γ production in the lungs, and 3) restored the accumulation of major effector cell subsets. CCL7 administration abolished the difference in lung fungal burdens between TLR9(+/+) and TLR9(-/-) mice at week 3; however, significant reduction of fungal burdens between PBS- and CCL7-treated mice has not been observed, suggesting that additional mechanism(s) apart from early CCL7 induction contribute to optimal fungal clearance in TLR9(+/+) mice. Collectively, we show that TLR9 signaling during the afferent phase contributes to the development of protective immunity by promoting the early induction of CCL7 and IFN-γ and the subsequent early recruitment and activation of DCs and additional effector cells in mice with cryptococcal pneumonia.


Subject(s)
Chemokine CCL7/immunology , Cryptococcosis/immunology , Cryptococcus neoformans , Lung/immunology , Pneumonia/immunology , Animals , CD11b Antigen/immunology , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Cell Communication/immunology , Colony Count, Microbial , Cryptococcosis/complications , Cryptococcosis/microbiology , Dendritic Cells/immunology , Dendritic Cells/metabolism , Female , Interferon-gamma/immunology , Lung/metabolism , Lung/microbiology , Macrophages/immunology , Macrophages/metabolism , Mice , Mice, Inbred BALB C , Mice, Knockout , Monocyte Chemoattractant Proteins/immunology , Pneumonia/complications , Pneumonia/microbiology , Signal Transduction , Toll-Like Receptor 9/deficiency , Toll-Like Receptor 9/genetics , Toll-Like Receptor 9/immunology
3.
Thorax ; 67(5): 456-63, 2012 May.
Article in English | MEDLINE | ID: mdl-22318161

ABSTRACT

The composition of the lung microbiome contributes to both health and disease, including obstructive lung disease. Because it has been estimated that over 70% of the bacterial species on body surfaces cannot be cultured by currently available techniques, traditional culture techniques are no longer the gold standard for microbial investigation. Advanced techniques that identify bacterial sequences, including the 16S ribosomal RNA gene, have provided new insights into the depth and breadth of microbiota present both in the diseased and normal lung. In asthma, the composition of the microbiome of the lung and gut during early childhood development may play a key role in the development of asthma, while specific airway microbiota are associated with chronic asthma in adults. Early bacterial stimulation appears to reduce asthma susceptibility by helping the immune system develop lifelong tolerance to innocuous antigens. By contrast, perturbations in the microbiome from antibiotic use may increase the risk for asthma development. In chronic obstructive pulmonary disease, bacterial colonisation has been associated with a chronic bronchitic phenotype, increased risk of exacerbations, and accelerated loss of lung function. In cystic fibrosis, studies utilising culture-independent methods have identified associations between decreased bacterial community diversity and reduced lung function; colonisation with Pseudomonas aeruginosa has been associated with the presence of certain CFTR mutations. Genomic analysis of the lung microbiome is a young field, but has the potential to define the relationship between lung microbiome composition and disease course. Whether we can manipulate bacterial communities to improve clinical outcomes remains to be seen.


Subject(s)
Cystic Fibrosis/microbiology , Lung Diseases, Obstructive/microbiology , Lung/microbiology , Metagenome , Respiratory Mucosa/immunology , Humans , Lung/pathology , Smoking
4.
Appl Environ Microbiol ; 78(7): 2359-66, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22286988

ABSTRACT

Little is known about the dynamics of early ecological succession during experimental conventionalization of the gastrointestinal (GI) tract; thus, we measured changes in bacterial communities over time, at two different mucosal sites (cecum and jejunum), with germfree C57BL/6 mice as the recipients of cecal contents (input community) from a C57BL/6 donor mouse. Bacterial communities were monitored using pyrosequencing of 16S rRNA gene amplicon libraries from the cecum and jejunum and analyzed by a variety of ecological metrics. Bacterial communities, at day 1 postconventionalization, in the cecum and jejunum had lower diversity and were distinct from the input community (dominated by either Escherichia or Bacteroides). However, by days 7 and 21, the recipient communities had become significantly diverse and the cecal communities resembled those of the donor and donor littermates, confirming that transfer of cecal contents results in reassembly of the community in the cecum 7 to 21 days later. However, bacterial communities in the recipient jejunum displayed significant structural heterogeneity compared to each other or the donor inoculum or the donor littermates, suggesting that the bacterial community of the jejunum is more dynamic during the first 21 days of conventionalization. This report demonstrates that (i) mature input communities do not simply reassemble at mucosal sites during conventionalization (they first transform into a "pioneering" community and over time take on the appearance, in membership and structure, of the original input community) and (ii) the specific mucosal environment plays a role in shaping the community.


Subject(s)
Bacteria/classification , Bacteria/growth & development , Cecum/microbiology , Ecosystem , Germ-Free Life , Jejunum/microbiology , Animals , Bacteria/genetics , Bacteria/isolation & purification , Bacteroides/genetics , Bacteroides/growth & development , Bacteroides/isolation & purification , DNA, Bacterial/analysis , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , DNA, Ribosomal/genetics , Feces/microbiology , Genes, rRNA , Mice , Mice, Inbred C57BL , Polymerase Chain Reaction , Proteobacteria/genetics , Proteobacteria/growth & development , Proteobacteria/isolation & purification , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA/methods
5.
Infect Immun ; 80(4): 1424-36, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22252873

ABSTRACT

Previous research in our laboratory has demonstrated that repeated intranasal exposure to Aspergillus fumigatus conidia in C57BL/6 mice results in a chronic pulmonary inflammatory response that reaches its maximal level after four challenges. The inflammatory response is characterized by eosinophilia, goblet cell metaplasia, and T helper T(H)2 cytokine production, which is accompanied by sustained interleukin-17 (IL-17) expression that persists even after the T(H)2 response has begun to resolve. T(H)17 cells could develop in mice deficient in gamma interferon (IFN-γ), IL-4, or IL-10. In the lungs of IL-17 knockout mice repeatedly challenged with A. fumigatus conidia, inflammation was attenuated (with the most significant decrease occurring in eosinophils), conidial clearance was enhanced, and the early transient peak of CD4(+) CD25(+) FoxP3(+) cells blunted. IL-17 appeared to play only a minor role in eosinophil differentiation in the bone marrow but a central role in eosinophil extravasation from the blood into the lungs. These observations point to an expanded role for IL-17 in driving T(H)2-type inflammation to repeated inhalation of fungal conidia.


Subject(s)
Aspergillus fumigatus/immunology , Aspergillus fumigatus/pathogenicity , Interleukin-17/immunology , Pulmonary Aspergillosis/immunology , Pulmonary Eosinophilia/immunology , Spores, Fungal/immunology , Animals , CD4 Antigens/biosynthesis , Eosinophils/immunology , Forkhead Transcription Factors/biosynthesis , Interferon-gamma/immunology , Interleukin-10/immunology , Interleukin-2 Receptor alpha Subunit/biosynthesis , Interleukin-4/immunology , Lung/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Pneumonia , Th17 Cells/immunology , Th2 Cells/immunology
6.
J Gerontol A Biol Sci Med Sci ; 67(7): 714-25, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22193547

ABSTRACT

Young (4 month) and aged (15-18 months) mice were given intranasal saline or γ--herpesvirus-68 infection. After 21 days, aged, but not young mice, showed significant increases in collagen content and fibrosis. There were no differences in viral clearance or inflammatory cells (including fibrocytes) between infected aged and young mice. Enzyme-linked immunosorbent assays showed increased transforming growth factor-ß in whole lung homogenates of infected aged mice compared with young mice. When fibroblasts from aged and young mice were infected in vitro, aged, but not young, fibroblasts upregulate alpha-smooth muscle actin and collagen I protein. Infection with virus in vivo also demonstrates increased alpha-smooth muscle actin and collagen I protein and collagen I, collagen III, and fibronectin messenger RNA in aged fibroblasts. Furthermore, evaluation revealed that aged fibroblasts at baseline have increased transforming growth factor-ß receptor 1 and 2 levels compared with young fibroblasts and are resistant to apoptosis. Increased responsiveness to transforming growth factor-ß was verified by increased collagen III and fibronectin messenger RNA after treatment in vitro with transforming growth factor-ß.


Subject(s)
Aging/immunology , Fibroblasts/physiology , Gammaherpesvirinae/pathogenicity , Herpesviridae Infections/complications , Pulmonary Fibrosis/etiology , Transforming Growth Factor beta/physiology , Animals , Apoptosis , Collagen Type III/biosynthesis , Cytokines/biosynthesis , Fibronectins/biosynthesis , Male , Mice , Mice, Inbred C57BL , Receptors, Transforming Growth Factor beta/analysis , Virus Activation
7.
Fibrogenesis Tissue Repair ; 4: 18, 2011 Aug 02.
Article in English | MEDLINE | ID: mdl-21810214

ABSTRACT

BACKGROUND: We have shown previously that murine gammaherpesvirus 68 (γHV68) infection exacerbates established pulmonary fibrosis. Because Toll-like receptor (TLR)-9 may be important in controlling the immune response to γHV68 infection, we examined how TLR-9 signaling effects exacerbation of fibrosis in response to viral infection, using models of bleomycin- and fluorescein isothiocyanate-induced pulmonary fibrosis in wild-type (Balb/c) and TLR-9-/- mice. RESULTS: We found that in the absence of TLR-9 signaling, there was a significant increase in collagen deposition following viral exacerbation of fibrosis. This was not associated with increased viral load in TLR-9-/- mice or with major alterations in T helper (Th)1 and Th2 cytokines. We examined alveolar epithelial-cell apoptosis in both strains, but this could not explain the altered fibrotic outcomes. As expected, TLR-9-/- mice had a defect in the production of interferon (IFN)-ß after viral infection. Balb/c fibroblasts infected with γHV68 in vitro produced more IFN-ß than did infected TLR-9-/- fibroblasts. Accordingly, in vitro infection of Balb/c fibroblasts resulted in reduced proliferation rates whereas infection of TLR-9-/- fibroblasts did not. Finally, therapeutic administration of CpG oligodeoxynucleotides ameliorated bleomycin-induced fibrosis in wild-type mice. CONCLUSIONS: These results show a protective role for TLR-9 signaling in murine models of lung fibrosis, and highlight differences in the biology of TLR-9 between mice and humans.

8.
PLoS One ; 6(6): e21253, 2011.
Article in English | MEDLINE | ID: mdl-21712985

ABSTRACT

BACKGROUND: Idiopathic pulmonary fibrosis exhibits differential progression from the time of diagnosis but the molecular basis for varying progression rates is poorly understood. The aim of the present study was to ascertain whether differential miRNA expression might provide one explanation for rapidly versus slowly progressing forms of IPF. METHODOLOGY AND PRINCIPAL FINDINGS: miRNA and mRNA were isolated from surgical lung biopsies from IPF patients with a clinically documented rapid or slow course of disease over the first year after diagnosis. A quantitative PCR miRNA array containing 88 of the most abundant miRNA in the human genome was used to profile lung biopsies from 9 patients with rapidly progressing IPF, 6 patients with slowly progressing IPF, and 10 normal lung biopsies. Using this approach, 11 miRNA were significantly increased and 36 were significantly decreased in rapid biopsies compared with normal biopsies. Slowly progressive biopsies exhibited 4 significantly increased miRNA and 36 significantly decreased miRNA compared with normal lung. Among the miRNA present in IPF with validated mRNA targets were those with regulatory effects on epithelial-mesenchymal transition (EMT). Five miRNA (miR-302c, miR-423-5p, miR-210, miR-376c, and miR-185) were significantly increased in rapid compared with slow IPF lung biopsies. Additional analyses of rapid biopsies and fibroblasts grown from the same biopsies revealed that the expression of AGO1 and AGO2 (essential components of the miRNA processing RISC complex) were lower compared with either slow or normal lung biopsies and fibroblasts. CONCLUSION: These findings suggest that the development and/or clinical progression of IPF might be the consequence of aberrant miRNA processing.


Subject(s)
Disease Progression , Idiopathic Pulmonary Fibrosis/genetics , Idiopathic Pulmonary Fibrosis/physiopathology , MicroRNAs/metabolism , Aged , Argonaute Proteins/genetics , Argonaute Proteins/metabolism , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/metabolism , Epithelial-Mesenchymal Transition/physiology , Eukaryotic Initiation Factors/genetics , Eukaryotic Initiation Factors/metabolism , Female , Humans , Idiopathic Pulmonary Fibrosis/pathology , Lung/cytology , Lung/pathology , Lung/physiology , Male , MicroRNAs/genetics , Middle Aged , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Retrospective Studies , Ribonuclease III/genetics , Ribonuclease III/metabolism , Young Adult
9.
Am J Respir Cell Mol Biol ; 45(4): 809-16, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21378261

ABSTRACT

Multipotent mesenchymal progenitor cells, termed "mesenchymal stem cells" (MSCs), have been demonstrated to reside in human adult lungs. However, there is little information regarding the associations of these local mesenchymal progenitors with other resident somatic cells and their potential for therapeutic use. Here we provide in vivo and in vitro evidence for the ability of human adult lung-resident MSCs (LR-MSCs) to interact with the local epithelial cells. The in vivo retention and localization of human LR-MSCs in an alveolar microenvironment was investigated by placing PKH-26 or DsRed lentivirus-labeled human LR-MSCs in the lungs of immunodeficient (SCID) mice. At 3 weeks after intratracheal administration, 19.3 ± 3.21% of LR-MSCs were recovered, compared with 3.47 ± 0.51% of control fibroblasts, as determined by flow cytometry. LR-MSCs were found to persist in murine lungs for up to 6 months and demonstrated preferential localization to the corners of the alveoli in close proximity to type II alveolar epithelial cells, the progenitor cells of the alveolar epithelium. In vitro, LR-MSCs established gap junction communications with lung alveolar and bronchial epithelial cells and demonstrated an ability to secrete keratinocyte growth factor, an important modulator of epithelial cell proliferation and differentiation. Gap junction communications were also demonstrable between LR-MSCs and resident murine cells in vivo. This study demonstrates, for the first time, an ability of tissue-specific MSCs to engraft in their organ of origin and establishes a pathway of bidirectional interaction between these mesenchymal progenitors and adult somatic epithelial cells in the lung.


Subject(s)
Alveolar Epithelial Cells/metabolism , Cell Communication , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/metabolism , Pulmonary Alveoli/surgery , Animals , Cell Separation/methods , Cell Tracking , Cells, Cultured , Enzyme-Linked Immunosorbent Assay , Female , Fibroblast Growth Factor 7/metabolism , Flow Cytometry , Fluorescent Dyes/metabolism , Gap Junctions/metabolism , Genetic Vectors , Graft Survival , Humans , Lentivirus/genetics , Luminescent Proteins/biosynthesis , Luminescent Proteins/genetics , Mice , Mice, SCID , Organic Chemicals/metabolism , Pulmonary Alveoli/metabolism , Time Factors , Transfection , Red Fluorescent Protein
10.
Infect Immun ; 79(5): 1915-26, 2011 May.
Article in English | MEDLINE | ID: mdl-21383052

ABSTRACT

The immune response to Cryptococcus neoformans following pulmonary infection of C57BL/6 wild-type (WT) mice results in the development of persistent infection with characteristics of allergic bronchopulmonary mycosis (ABPM). To further clarify the role of Th1/Th2 polarizing cytokines in this model, we performed kinetic analysis of cytokine responses and compared cytokine profiles, pathologies, and macrophage (Mac) polarization status in C. neoformans-infected WT, interleukin-4-deficient (IL-4(-/-)), and gamma interferon-deficient (IFN-γ(-/-)) C57BL/6 mice. Results show that cytokine expression in the infected WT mice is not permanently Th2 biased but changes dynamically over time. Using multiple Mac activation markers, we further demonstrate that IL-4 and IFN-γ regulate the polarization state of Macs in this model. A higher IL-4/IFN-γ ratio leads to the development of alternatively activated Macs (aaMacs), whereas a higher IFN-γ/IL-4 ratio leads to the generation of classically activated Macs (caMacs). WT mice that coexpress IL-4 and IFN-γ during fungal infection concurrently display both types of Mac polarization markers. Concurrent stimulation of Macs with IFN-γ and IL-4 results in an upregulation of both sets of markers within the same cells, i.e., formation of an intermediate aaMac/caMac phenotype. These cells express both inducible nitric oxide synthase (important for clearance) and arginase (associated with chronic/progressive infection). Together, our data demonstrate that the interplay between Th1 and Th2 cytokines supports chronic infection, chronic inflammation, and the development of ABPM pathology in C. neoformans-infected lungs. This cytokine interplay modulates Mac differentiation, including generation of an intermediate caMac/aaMac phenotype, which in turn may support chronic "steady-state" fungal infection and the resultant ABPM pathology.


Subject(s)
Cryptococcosis/immunology , Cytokines/immunology , Lung Diseases, Fungal/immunology , Macrophage Activation/immunology , Macrophages/immunology , Animals , Cryptococcosis/pathology , Cryptococcus neoformans/immunology , Female , Fluorescent Antibody Technique , Immunohistochemistry , Interleukin-4/deficiency , Lung Diseases, Fungal/pathology , Mice , Mice, Inbred C57BL , Reverse Transcriptase Polymerase Chain Reaction , Th1 Cells/immunology , Th2 Cells/immunology
11.
PLoS One ; 6(2): e16384, 2011 Feb 22.
Article in English | MEDLINE | ID: mdl-21364979

ABSTRACT

Although culture-independent techniques have shown that the lungs are not sterile, little is known about the lung microbiome in chronic obstructive pulmonary disease (COPD). We used pyrosequencing of 16S amplicons to analyze the lung microbiome in two ways: first, using bronchoalveolar lavage (BAL) to sample the distal bronchi and air-spaces; and second, by examining multiple discrete tissue sites in the lungs of six subjects removed at the time of transplantation. We performed BAL on three never-smokers (NS) with normal spirometry, seven smokers with normal spirometry ("healthy smokers", HS), and four subjects with COPD (CS). Bacterial 16 s sequences were found in all subjects, without significant quantitative differences between groups. Both taxonomy-based and taxonomy-independent approaches disclosed heterogeneity in the bacterial communities between HS subjects that was similar to that seen in healthy NS and two mild COPD patients. The moderate and severe COPD patients had very limited community diversity, which was also noted in 28% of the healthy subjects. Both approaches revealed extensive membership overlap between the bacterial communities of the three study groups. No genera were common within a group but unique across groups. Our data suggests the existence of a core pulmonary bacterial microbiome that includes Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus, Veillonella, and Porphyromonas. Most strikingly, there were significant micro-anatomic differences in bacterial communities within the same lung of subjects with advanced COPD. These studies are further demonstration of the pulmonary microbiome and highlight global and micro-anatomic changes in these bacterial communities in severe COPD patients.


Subject(s)
Health , Lung/microbiology , Metagenome , Pulmonary Disease, Chronic Obstructive/microbiology , Smoking/pathology , Adult , Aged , Bronchoalveolar Lavage Fluid/microbiology , Bronchoscopy , DNA, Bacterial/analysis , Female , Humans , Lung/pathology , Male , Metagenome/genetics , Middle Aged , Pulmonary Disease, Chronic Obstructive/pathology , RNA, Ribosomal, 16S/analysis , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA
12.
Am J Pathol ; 178(1): 198-211, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21224057

ABSTRACT

Clearance of pulmonary infection with the fungal pathogen Cryptococcus neoformans is associated with the accumulation and activation of lung macrophages. However, the phenotype of these macrophages and the mechanisms contributing to their accumulation are not well-defined. In this study, we used an established murine model of cryptococcal lung infection and flow cytometric analysis to identify alveolar macrophages (AMs) and the recently described exudate macrophages (ExMs). Exudate macrophages are distinguished from AMs by their strong expression of CD11b and major histocompatibility complex class II and modest expression of costimulatory molecules. Exudate macrophages substantially outnumber AMs during the effector phase of the immune response; and accumulation of ExMs, but not AMs, was chemokine receptor 2 (CCR2) dependent and attributable to the recruitment and subsequent differentiation of Ly-6C(high) monocytes originating from the bone marrow and possibly the spleen. Peak ExM accumulation in wild-type (CCR2(+/+)) mice coincided with maximal lung expression of mRNA for inducible nitric oxide synthase and correlated with the known onset of cryptococcal clearance in this strain of mice. Exudate macrophages purified from infected lungs displayed a classically activated effector phenotype characterized by cryptococcal-enhanced production of inducible nitric oxide synthase and tumor necrosis factor α. Cryptococcal killing by bone marrow-derived ExMs was CCR2 independent and superior to that of AMs. We conclude that clearance of cryptococcal lung infection requires the CCR2-mediated massive accumulation of fungicidal ExMs derived from circulating Ly-6C(high) monocytes.


Subject(s)
Cryptococcosis/immunology , Cryptococcus neoformans/immunology , Macrophages, Alveolar/immunology , Macrophages, Alveolar/microbiology , Pneumonia/immunology , Receptors, CCR2/immunology , Animals , Antigens, Ly/immunology , CD11 Antigens/immunology , Disease Models, Animal , Exudates and Transudates/immunology , Female , Flow Cytometry , Histocompatibility Antigens Class II/immunology , Mice , Mice, Mutant Strains , Pneumonia/microbiology , Receptors, CCR2/genetics
13.
Am J Respir Crit Care Med ; 183(8): 1062-70, 2011 Apr 15.
Article in English | MEDLINE | ID: mdl-21169468

ABSTRACT

RATIONALE: Bronchoalveolar lavage fluid (BAL) from human lung allografts demonstrates the presence of a multipotent mesenchymal stromal cell population. However, the clinical relevance of this novel cellular component of BAL and its association with bronchiolitis obliterans syndrome (BOS), a disease marked by progressive airflow limitation secondary to fibrotic obliteration of the small airways, remains to be determined. OBJECTIVES: In this study we investigate the association of number of mesenchymal stromal cells in BAL with development of BOS in human lung transplant recipients. METHODS: Mesenchymal colony-forming units (CFUs) were quantitated in a cohort of 405 BAL samples obtained from 162 lung transplant recipients. Poisson generalized estimating equations were used to determine the predictors of BAL mesenchymal CFU count. MEASUREMENTS AND MAIN RESULTS: Higher CFU counts were noted early post-transplantation; time from transplant to BAL of greater than 3 months predicted 0.4-fold lower CFU counts (P = 0.0001). BOS diagnosis less than or equal to 365 days before BAL was associated with a 2.11-fold higher CFU count (P = 0.02). There were 2.62- and 2.70-fold higher CFU counts noted in the presence of histologic diagnosis of bronchiolitis obliterans (P = 0.05) and organizing pneumonia (0.0003), respectively. In BAL samples obtained from BOS-free patients greater than 6 months post-transplantation (n = 173), higher mesenchymal CFU counts (≥10) significantly predicted BOS onset in both univariate (hazard ratio, 5.61; 95% CI, 3.03-10.38; P < 0.0001) and multivariate (hazard ratio, 5.02; 95% CI, 2.40-10.51; P < 0.0001) Cox regression analysis. CONCLUSIONS: Measurement of mesenchymal CFUs in the BAL provides predictive information regarding future BOS onset.


Subject(s)
Bronchiolitis Obliterans/etiology , Bronchoalveolar Lavage Fluid/cytology , Lung Transplantation/adverse effects , Mesenchymal Stem Cells/physiology , Adult , Aged , Biomarkers , Female , Flow Cytometry , Humans , Male , Middle Aged , Poisson Distribution , Predictive Value of Tests , Proportional Hazards Models , Statistics, Nonparametric , Stem Cells/cytology , Young Adult
14.
Am J Physiol Lung Cell Mol Physiol ; 300(2): L274-85, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21036917

ABSTRACT

Although γherpesvirus infections are associated with enhanced lung fibrosis in both clinical and animal studies, there is limited understanding about fibrotic effects of γherpesviruses on cell types present in the lung, particularly during latent infection. Wild-type mice were intranasally infected with a murine γherpesvirus (γHV-68) or mock-infected with saline. Twenty-eight days postinfection (dpi), ∼14 days following clearance of the lytic infection, alveolar macrophages (AMs), mesenchymal cells, and CD19-enriched cell populations from the lung and spleen express M(3) and/or glycoprotein B (gB) viral mRNA and harbor viral genome. AMs from infected mice express more transforming growth factor (TGF)-ß(1), CCL2, CCL12, TNF-α, and IFN-γ than AMs from mock-infected mice. Mesenchymal cells express more total TGF-ß(1), CCL12, and TNF-α than mesenchymal cells from mock-infected mice. Lung and spleen CD19-enriched cells express more total TGF-ß(1) 28 dpi compared with controls. The CD19-negative fraction of the spleen overexpresses TGF-ß(1) and harbors viral genome, but this likely represents infection of monocytes. Purified T cells from the lung harbor almost no viral genome. Purified T cells overexpress IL-10 but not TGF-ß(1). Intracellular cytokine staining demonstrated that lung T cells at 28 dpi produce IFN-γ but not IL-4. Thus infection with a murine γherpesvirus is sufficient to upregulate profibrotic and proinflammatory factors in a variety of lung resident and circulating cell types 28 dpi. Our results provide new information about possible contributions of these cells to fibrogenesis in the lungs of individuals harboring a γherpesvirus infection and may help explain why γHV-68 infection can augment or exacerbate fibrotic responses in mice.


Subject(s)
Cytokines/biosynthesis , Herpesviridae Infections/immunology , Pulmonary Fibrosis/etiology , Rhadinovirus/pathogenicity , Tumor Virus Infections/immunology , Animals , Base Sequence , Chemokine CCL2/biosynthesis , DNA Primers/genetics , DNA, Viral/genetics , Disease Models, Animal , Herpesviridae Infections/genetics , Herpesviridae Infections/virology , Interferon-gamma/biosynthesis , Interleukin-10/biosynthesis , Lung/immunology , Lung/virology , Macrophage Activation , Macrophages, Alveolar/immunology , Macrophages, Alveolar/virology , Male , Mesoderm/immunology , Mesoderm/virology , Mice , Mice, Inbred C57BL , Monocyte Chemoattractant Proteins/biosynthesis , Pulmonary Fibrosis/genetics , Pulmonary Fibrosis/immunology , Pulmonary Fibrosis/virology , Spleen/immunology , Spleen/virology , T-Lymphocytes/immunology , T-Lymphocytes/virology , Transforming Growth Factor beta1/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Virus Infections/genetics , Tumor Virus Infections/virology , Viral Load
15.
Infect Immun ; 79(1): 125-35, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21041495

ABSTRACT

Aspergillus fumigatus, a ubiquitous airborne fungus, can cause invasive infection in immunocompromised individuals but also triggers allergic bronchopulmonary aspergillosis in a subset of otherwise healthy individuals repeatedly exposed to the organism. This study addresses a critical gap in our understanding of the immunoregulation in response to repeated exposure to A. fumigatus conidia. C57BL/6 mice were challenged intranasally with A. fumigatus conidia weekly, and leukocyte composition, activation, and cytokine production were examined after two, four, and eight challenges. Approximately 99% of A. fumigatus conidia were cleared within 24 h after inoculation, and repeated exposure to A. fumigatus conidia did not result in hyphal growth or accumulation of conidia with time. After 2 challenges, there was an early influx of neutrophils and regulatory T (T(reg)) cells into the lungs but minimal inflammation. Repeated exposure promoted sustained expansion of the draining lymph nodes, while the influx of eosinophils and other myeloid cells into the lungs peaked after four exposures and then decreased despite continued A. fumigatus challenges. Goblet cell metaplasia and low-level fibrosis were evident during the response. Repeated exposure to A. fumigatus conidia induced T cell activation in the lungs and the codevelopment by four exposures of T(H)1, T(H)2, and T(H)17 responses in the lungs, which were maintained through eight exposures. Changes in CD4 T cell polarization or T(reg) numbers did not account for the reduction in myeloid cell numbers later in the response, suggesting a non-T-cell regulatory pathway involved in dampening inflammation during repeated exposure to A. fumigatus conidia.


Subject(s)
Aspergillus fumigatus/immunology , Pulmonary Aspergillosis/immunology , Th1 Cells/physiology , Th17 Cells/physiology , Th2 Cells/physiology , Animals , CD4-Positive T-Lymphocytes , Inflammation/immunology , Inflammation/pathology , Lung/cytology , Mice , Mice, Inbred C57BL , Spores, Fungal/immunology , Time Factors
16.
Sci Transl Med ; 2(57): 57ra82, 2010 Nov 10.
Article in English | MEDLINE | ID: mdl-21068441

ABSTRACT

Idiopathic pulmonary fibrosis is characterized by diffuse alveolar damage and severe fibrosis, resulting in a steady worsening of lung function and gas exchange. Because idiopathic pulmonary fibrosis is a generally progressive disorder with highly heterogeneous disease progression, we classified affected patients as either rapid or slow progressors over the first year of follow-up and then identified differences between the two groups to investigate the mechanism governing rapid progression. Previous work from our laboratory has demonstrated that Toll-like receptor 9 (TLR9), a pathogen recognition receptor that recognizes unmethylated CpG motifs in bacterial and viral DNA, promotes myofibroblast differentiation in lung fibroblasts cultured from biopsies of patients with idiopathic pulmonary fibrosis. Therefore, we hypothesized that TLR9 functions as both a sensor of pathogenic molecules and a profibrotic signal in rapidly progressive idiopathic pulmonary fibrosis. Indeed, TLR9 was present at higher concentrations in surgical lung biopsies from rapidly progressive patients than in tissue from slowly progressing patients. Moreover, fibroblasts from rapid progressors were more responsive to the TLR9 agonist, CpG DNA, than were fibroblasts from slowly progressing patients. Using a humanized severe combined immunodeficient mouse, we then demonstrated increased fibrosis in murine lungs receiving human lung fibroblasts from rapid progressors compared with mice receiving fibroblasts from slowly progressing patients. This fibrosis was exacerbated by intranasal CpG challenges. Furthermore, CpG induced the differentiation of blood monocytes into fibrocytes and the epithelial-to-mesenchymal transition of A549 lung epithelial cells. These data suggest that TLR9 may drive the pathogenesis of rapidly progressive idiopathic pulmonary fibrosis and may serve as a potential indicator for this subset of the disease.


Subject(s)
Idiopathic Pulmonary Fibrosis/physiopathology , Toll-Like Receptor 9/physiology , Aged , Cell Differentiation , Cell Line , CpG Islands , DNA, Bacterial/metabolism , DNA, Viral/metabolism , Disease Progression , Epithelial-Mesenchymal Transition , Female , Humans , Idiopathic Pulmonary Fibrosis/pathology , Male , Middle Aged , Toll-Like Receptor 9/metabolism
17.
Chest ; 138(3): 693-703, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20822991

ABSTRACT

Idiopathic pulmonary fibrosis (IPF), a heterogeneous disease with respect to clinical presentation and rates of progression, disproportionately affects older adults. The diagnosis of IPF is descriptive, based on clinical, radiologic, and histopathologic examination, and definitive diagnosis is hampered by poor interobserver agreement and lack of a consensus definition. There are no effective treatments. Cellular, molecular, genetic, and environmental risk factors have been identified for IPF, but the initiating event and the characteristics of preclinical stages are not known. IPF is predominantly a disease of older adults, and the processes underlying normal aging might significantly influence the development of IPF. Yet, the biology of aging and the principles of medical care for this population have been typically ignored in basic, translational, or clinical IPF research. In August 2009, the Association of Specialty Professors, in collaboration with the American College of Chest Physicians, the American Geriatrics Society, the National Institute on Aging, and the National Heart, Lung, and Blood Institute, held a workshop, summarized herein, to review what is known, to identify research gaps at the interface of aging and IPF, and to suggest priority areas for future research. Efforts to answer the questions identified will require the integration of geriatrics, gerontology, and pulmonary research, but these efforts have great potential to improve care for patients with IPF.


Subject(s)
Aging/physiology , Biomedical Research/organization & administration , Geriatrics/organization & administration , Health Priorities/organization & administration , Idiopathic Pulmonary Fibrosis , Aged , Humans , Idiopathic Pulmonary Fibrosis/diagnosis , Idiopathic Pulmonary Fibrosis/etiology , Idiopathic Pulmonary Fibrosis/therapy , Middle Aged
18.
Am J Pathol ; 177(5): 2459-71, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20864680

ABSTRACT

Persistent pulmonary infection with Cryptococcus neoformans in C57BL/6 mice results in chronic inflammation that is characterized by an injurious Th2 immune response. In this study, we performed a comparative analysis of cryptococcal infection in wild-type versus CD40-deficient mice (in a C57BL/6 genetic background) to define two important roles of CD40 in the modulation of fungal clearance as well as Th2-mediated immunopathology. First, CD40 promoted microanatomic containment of the organism within the lung tissue. This protective effect was associated with: i) a late reduction in fungal burden within the lung; ii) a late accumulation of lung leukocytes, including macrophages, CD4+ T cells, and CD8+ T cells; iii) both early and late production of tumor necrosis factor-α and interferon-γ by lung leukocytes; and iv) early IFN-γ production at the site of T cell priming in the regional lymph nodes. In the absence of CD40, systemic cryptococcal dissemination was increased, and mice died of central nervous system infection. Second, CD40 promoted pathological changes in the airways, including intraluminal mucus production and subepithelial collagen deposition, but did not alter eosinophil recruitment or the alternative activation of lung macrophages. Collectively, these results demonstrate that CD40 helps limit progressive cryptococcal growth in the lung and protects against lethal central nervous system dissemination. CD40 also promotes some, but not all, elements of Th2-mediated immunopathology in response to persistent fungal infection in the lung.


Subject(s)
CD40 Antigens/immunology , Cryptococcosis , Cryptococcus neoformans/physiology , Lung Diseases, Fungal , Lung , Animals , CD40 Antigens/genetics , Cells, Cultured , Central Nervous System Fungal Infections/immunology , Central Nervous System Fungal Infections/microbiology , Cryptococcosis/immunology , Cryptococcosis/microbiology , Cryptococcosis/pathology , Cryptococcus neoformans/immunology , Interferon-gamma/immunology , Leukocytes/cytology , Leukocytes/immunology , Lung/immunology , Lung/microbiology , Lung/pathology , Lung Diseases, Fungal/immunology , Lung Diseases, Fungal/microbiology , Lung Diseases, Fungal/pathology , Macrophages/cytology , Macrophages/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout
19.
Am J Pathol ; 177(2): 754-65, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20581055

ABSTRACT

To determine whether TLR9 signaling contributes to the development of the adaptive immune response to cryptococcal infection, wild-type (TLR9+/+) and TLR9 knockout (TLR9-/-) BALB/c mice were infected intratracheally with 10(4) C. neoformans 52D. We evaluated 1) organ microbial burdens, 2) pulmonary leukocyte recruitment, 3) pulmonary and systemic cytokine induction, and 4) macrophage activation profiles. TLR9 deletion did not affect pulmonary growth during the innate phase, but profoundly impaired pulmonary clearance during the adaptive phase of the immune response (a 1000-fold difference at week 6). The impaired clearance in TLR9-/- mice was associated with: 1) significantly reduced CD4(+), CD8+ T cell, and CD19+ B cell recruitment into the lungs; 2) defects in Th polarization indicated by altered cytokine responses in the lungs, lymphonodes, and spleen; and 3) diminished macrophage accumulation and altered activation profile, including robust up-regulation of Arg1 and FIZZ1 (indicators of alternative activation) and diminished induction of inducible nitric oxide synthase (an indicator of classical activation). Histological analysis revealed defects in granuloma formation and increased numbers of intracellular yeast residing within macrophages in the lungs of TLR9-/- mice. We conclude that TLR9 signaling plays an important role in the development of robust protective immunity, proper recruitment and function of effector cells (lymphocytes and macrophages), and, ultimately, effective cryptococcal clearance from the infected lungs.


Subject(s)
Adaptive Immunity/immunology , Cryptococcosis/immunology , Cryptococcus neoformans/immunology , Lung Diseases , Signal Transduction/immunology , Toll-Like Receptor 9/metabolism , Animals , Cryptococcus neoformans/pathogenicity , Cytokines/immunology , Female , Humans , Lung Diseases/immunology , Lung Diseases/microbiology , Lung Diseases/pathology , Mice , Mice, Inbred BALB C , Mice, Knockout , T-Lymphocyte Subsets/immunology , T-Lymphocytes, Helper-Inducer/immunology , Toll-Like Receptor 9/genetics
20.
J Clin Invest ; 120(6): 1950-60, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20501949

ABSTRACT

Plasminogen activation to plasmin protects from lung fibrosis, but the mechanism underlying this antifibrotic effect remains unclear. We found that mice lacking plasminogen activation inhibitor-1 (PAI-1), which are protected from bleomycin-induced pulmonary fibrosis, exhibit lung overproduction of the antifibrotic lipid mediator prostaglandin E2 (PGE2). Plasminogen activation upregulated PGE2 synthesis in alveolar epithelial cells, lung fibroblasts, and lung fibrocytes from saline- and bleomycin-treated mice, as well as in normal fetal and adult primary human lung fibroblasts. This response was exaggerated in cells from Pai1-/- mice. Although enhanced PGE2 formation required the generation of plasmin, it was independent of proteinase-activated receptor 1 (PAR-1) and instead reflected proteolytic activation and release of HGF with subsequent induction of COX-2. That the HGF/COX-2/PGE2 axis mediates in vivo protection from fibrosis in Pai1-/- mice was demonstrated by experiments showing that a selective inhibitor of the HGF receptor c-Met increased lung collagen to WT levels while reducing COX-2 protein and PGE2 levels. Of clinical interest, fibroblasts from patients with idiopathic pulmonary fibrosis were found to be defective in their ability to induce COX-2 and, therefore, unable to upregulate PGE2 synthesis in response to plasmin or HGF. These studies demonstrate crosstalk between plasminogen activation and PGE2 generation in the lung and provide a mechanism for the well-known antifibrotic actions of the fibrinolytic pathway.


Subject(s)
Cyclooxygenase 2/biosynthesis , Dinoprostone/biosynthesis , Plasminogen Activator Inhibitor 1/metabolism , Plasminogen/metabolism , Pulmonary Fibrosis/metabolism , Adult , Animals , Bleomycin/adverse effects , Bleomycin/metabolism , Bleomycin/pharmacology , Collagen/adverse effects , Collagen/metabolism , Collagen/pharmacology , Dinoprostone/metabolism , Dinoprostone/pharmacology , Extracellular Matrix/metabolism , Fibrinolysin , Fibroblasts/drug effects , Fibroblasts/metabolism , Fibroblasts/pathology , Fibrosis/metabolism , Fibrosis/pathology , Humans , Lung/drug effects , Lung/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Plasminogen/adverse effects , Plasminogen/pharmacology , Plasminogen Activator Inhibitor 1/adverse effects , Plasminogen Activator Inhibitor 1/pharmacology , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/pathology , Receptor, PAR-1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...